[{"AccountsPayableCurrent_0_Q3_USD":7982000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3_Q3_USD":6006000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q3_USD":2565000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-6006000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-2565000.0,"OtherAssetsNoncurrent_0_Q3_USD":15370000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":66227000.0,"OperatingLeasePayments_3_Q3_USD":5200000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":36121000.0,"OperatingLeaseLiability_0_Q3_USD":40109000.0,"OperatingIncomeLoss_3_Q3_USD":-143438000.0,"OperatingIncomeLoss_1_Q3_USD":-48436000.0,"OperatingExpenses_3_Q3_USD":226153000.0,"OperatingExpenses_1_Q3_USD":76999000.0,"NoncontrollingInterestIncreaseFromBusinessCombination_3_Q3_USD":64000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-36000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-11000.0,"NetIncomeLoss_3_Q3_USD":-140790000.0,"NetIncomeLoss_1_Q3_USD":-47688000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-180537000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":195564000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":30746000.0,"MinorityInterestDecreaseFromRedemptions_3_Q3_USD":943000.0,"MinorityInterest_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":131898000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":772398000.0,"Liabilities_0_Q3_USD":366382000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1500000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":9686000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1155000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":7085000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-45000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":7631000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":144173000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":145399000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":1594000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":617000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":27099000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":2367000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":2054000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":406016000.0,"StockholdersEquity_0_Q3_USD":406016000.0,"ShareBasedCompensation_3_Q3_USD":24880000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1349000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":82715000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":28563000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-918771000.0,"RestrictedCashNoncurrent_0_Q3_USD":1500000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1500000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":179018000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q3_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":2988000.0,"PaymentsToAcquireAdditionalInterestInSubsidiaries_3_Q3_USD":119000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":300387000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":20420000.0,"PreferredStockValue_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":7233000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":15396000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_3_Q3_USD":509620000.0,"ProceedsFromSaleOfHeldToMaturitySecurities_3_Q3_USD":6870000.0,"ProfitLoss_1_Q3_USD":-47688000.0,"ProfitLoss_3_Q3_USD":-140801000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":50816000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":62498000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":4582000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":7305000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":6987000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":49795000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-11000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-146832000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-50298000.0,"CommonStockValue_0_Q3_USD":1455000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":45625000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":178454000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":176954000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":650000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":95631000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":246459000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":342090000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":246460000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":95630000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":342080000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":47000.0,"AccountsReceivableNetCurrent_0_Q3_USD":7967000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-2394000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":18646000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":14816000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-623000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1323955000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-50298000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7873000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7873000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":24880000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":15838002.0,"Assets_0_Q3_USD":772398000.0,"AssetsCurrent_0_Q3_USD":447396000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":57000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":24880000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":145399000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-146843000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":90454000.0,"InterestReceivableCurrent_0_Q3_USD":620000.0,"InterestAndOtherIncome_3_Q3_USD":3010000.0,"InterestAndOtherIncome_1_Q3_USD":834000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":54928000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6467000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":1204000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-1932000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-62292000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_3_Q3_USD":-415000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2743000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-4699000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":373000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":86000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-140428000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-47602000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"GoodwillAndIntangibleAssetImpairment_3_Q3_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":183943000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_1_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_3_Q3_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":6789000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6675000.0,"EarningsPerShareBasic_1_Q3_USD":-0.33,"ContractualObligation_0_Q3_USD":12281000.0,"EarningsPerShareBasic_3_Q3_USD":-0.98,"EarningsPerShareDiluted_3_Q3_USD":-0.98,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-148000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":30000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":14501000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":47135000.0,"Goodwill_0_Q3_USD":40530000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":144173000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]